← FDA Medical Device Classifications

Assay, Direct, Nucleic Acid Amplification, Respiratory Syncytial Virus

NHY · Class I — Low Risk (general controls) · Microbiology · 21 CFR 866.3480

Classification

FDA Product Code
NHY
Device class
Class I — Low Risk (general controls)
Regulation
21 CFR 866.3480
Review panel
MI
Medical specialty
Microbiology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
Y

Definition

These reagents are nucleic acid primers and probes for the amplification and identification of Respiratory Syncytial virus directly from clinical specimens. The identification aids in the diagnosis of influenza and provides epidemiological information on this disease. This reagent differs from the description in the regulation in that it consists of nucleic acid primers and probes rather than antisera.

Market data

Cleared 510(k) submissions
0
Registered establishments
0

Source

Authoritative
FDA Device Classification database
Machine
JSON-LD · Markdown